Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-22,481
Closed -$2.18M 2
2017
Q4
$2.18M Sell
22,481
-2,634
-10% -$248K 0.15% 92
2017
Q3
$2.23M Sell
25,115
-1,999
-7% -$152K 0.16% 105
2017
Q2
$1.98M Buy
27,114
+848
+3% +$57K 0.15% 109
2017
Q1
$1.71M Sell
26,266
-3,878
-13% -$244K 0.15% 101
2016
Q4
$1.89M Buy
30,144
+797
+3% +$48.6K 0.19% 86
2016
Q3
$1.85M Buy
29,347
+6,866
+31% +$444K 0.2% 86
2016
Q2
$1.41M Sell
22,481
-1,404
-6% -$85.5K 0.16% 102
2016
Q1
$1.37M Buy
23,885
+557
+2% +$31K 0.17% 92
2015
Q4
$1.39M Buy
23,328
+2,641
+13% +$152K 0.18% 93
2015
Q3
$1.15M Buy
20,687
+1,318
+7% +$85.8K 0.18% 102
2015
Q2
$1.36M Buy
19,369
+801
+4% +$52.3K 0.2% 105
2015
Q1
$1.08M Buy
18,568
+4,879
+36% +$295K 0.16% 123
2014
Q4
$915K Sell
13,689
-582
-4% -$36.7K 0.15% 132
2014
Q3
$828K Buy
14,271
+4,777
+50% +$265K 0.15% 129
2014
Q2
$539K Buy
9,494
+3,334
+54% +$175K 0.1% 170
2014
Q1
$315K Buy
6,160
+2
+0% +$101 0.07% 226
2013
Q4
$327K Sell
6,158
-73
-1% -$3.59K 0.07% 235
2013
Q3
$276K Buy
6,231
+577
+10% +$25.6K 0.06% 266
2013
Q2
$230K Buy
+5,654
New +$247K 0.05% 282

Other funds holding ABBV

IFC Holdings's ABBV Position: Q1 2018 in Review

IFC Holdings sold out of AbbVie (ABBV) in Q1 2018, closing a stake of 22,481 shares — an estimated $2.18M sold.

IFC Holdings first reported a position in ABBV in Q2 2013 and held it in 19 quarters. The position peaked at $2.23M in Q3 2017. 2,016 funds tracked by Wall St. Rank hold ABBV as of Q1 2018.

  • IFC Holdings reported no remaining AbbVie position as of Q1 2018 after selling out during the quarter.
  • IFC Holdings sold 22,481 AbbVie shares in Q1 2018, an estimated $2.18M.
  • IFC Holdings first reported a position in AbbVie in Q2 2013 and held it in 19 quarters.
  • IFC Holdings's AbbVie position peaked at $2.23M in Q3 2017.
  • 2,016 funds tracked by Wall St. Rank held AbbVie as of Q1 2018.

Based on IFC Holdings's 13F filing for Q1 2018.